Bioengineering

Paul Yock, MD

Publication Details

  • Neointimal progression and luminal narrowing in sirolimus-eluting stent treatment for bare metal in-stent restenosis: a quantitative intravascular ultrasound analysis.

    Sakurai R, Ako J, Hassan AH, Bonneau HN, Neumann FJ, Desmet W, Holmes DR, Yock PG, Fitzgerald PJ, Honda Y. Am Heart J. 2007; 154 (2): 361-5

    Recurrent restenosis may occur after drug-eluting stent implantation for in-stent restenosis (ISR) of bare metal stents (BMSs), especially in areas involving drug-eluting stent gaps.

    PubMedID: 17643589

Stanford Medicine Resources:

Footer Links: